Quadria-Backed Aragen Life Said to Plan $300 Million India IPO
Aragen Life Sciences Ltd., a contract research and manufacturing firm, is considering an initial public offering in Mumbai that could raise as much as $300 million, according to people familiar with the matter.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.